Phase 3 Generalized Anxiety Disorder trials recruiting now

All Generalized Anxiety Disorder trials, every phase

Other phases for Generalized Anxiety Disorder

Phase 3 Generalized Anxiety Disorder trials

• A Study to Asses Safety and Tolerability of ITI-1284 Given Alone or as an Additional Treatment in Participants With Generalized Anxiety Disorder (GAD)
  NCT07807865 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07759128 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• A Trial of the Efficacy and Safety of a Fixed Dose of SEP-363856 in Adults With Generalized Anxiety Disorder
  NCT07767903 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 5 locations
• Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
  NCT05772104 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Phase 3 Clinical Trial of Buagafuran Capsules in the Treatment of GAD
  NCT06243640 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Phase Ⅲ Clinical Trial of Buagafuran Capsules in the Treatment of GAD
  NCT06243614 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.